Show simple item record

dc.contributor.authorTomaszuk-Kazberuk, Anna
dc.identifier.citationTomaszuk-Kazberuk A. How to deal with patients with atrial fibrillation during an epidemic?. Eur J Transl Clin Med. 2020;3(1):53-59. DOI: 10.31373/ejtcm/120487en
dc.description.abstractPatients with atrial fibrillation (AF) due to old age and comorbidities are at a higher risk of SARS-CoV-2 infection. These patients should protect themselves by limiting contact with other people to an absolute minimum and they should be educated about hygiene, including careful hand washing. In general, the principles of antiarrhythmic drug treatment of quarantined, infected and asymptomatic individuals remain unchanged. In the hospital setting it is important to remember about possible interactions between anticoagulants, antibiotics, antiarrhythmic, antiviral and antimalarial drugs. The current pandemic also led to limitations regarding the implantation and control of implantable devices to an absolute minimum.en
dc.publisherMedical University of Gdańsken
dc.rightsUznanie autorstwa-Na tych samych warunkach 3.0 Polska*
dc.subjectatrial fibrillationen
dc.subjectSARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus- 2en
dc.subjectCoronavirus disease 2019en
dc.subjectnon-vitamin K oral anticoagulants (NOACsen
dc.titleHow to deal with patients with atrial fibrillation during an epidemic?en
dc.contributor.organizationMedical University of Białystoken

Files in this item


This item appears in the following Collection(s)

Show simple item record

Uznanie autorstwa-Na tych samych warunkach 3.0 Polska
Except where otherwise noted, this item's license is described as Uznanie autorstwa-Na tych samych warunkach 3.0 Polska